期刊文献+

Advances in understanding of idiopathic pulmonary fibrosis 被引量:10

Advances in understanding of idiopathic pulmonary fibrosis
原文传递
导出
摘要 Our understanding of idiopathic pulmonary fibrosis (IPF) has undergone major changes in recent years. IPF is the most common of the idiopathic interstitial pneumonias. It remains the most often diagnosed, accounting for 50% to 60% of all cases. It is also associated with a worse prognosis than most of the interstitial lung diseases. The number of deaths related to IPF is nearly 14 times greater than those from asbestosis, while a recent estimate has suggested prevalence in the United States ranging from 14.0 to 42.7 cases per 100 000 population, depending on the criteria used for diagnosis, Our understanding of idiopathic pulmonary fibrosis (IPF) has undergone major changes in recent years. IPF is the most common of the idiopathic interstitial pneumonias. It remains the most often diagnosed, accounting for 50% to 60% of all cases. It is also associated with a worse prognosis than most of the interstitial lung diseases. The number of deaths related to IPF is nearly 14 times greater than those from asbestosis, while a recent estimate has suggested prevalence in the United States ranging from 14.0 to 42.7 cases per 100 000 population, depending on the criteria used for diagnosis,
作者 WANG Zeng-li
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第7期844-857,共14页 中华医学杂志(英文版)
关键词 idiopathic pulmonary fibrosis adrenal cortex hormones immunosuppressive agents idiopathic pulmonary fibrosis adrenal cortex hormones immunosuppressive agents
  • 相关文献

参考文献90

  • 1Raghu G,Weycker D,Edelsberg J,Bradford WZ,Oster G.Incidence and prevalence of idiopathic pulmonary fibrosis.Am J Respire Crit Care Med 2006;174:810-816.
  • 2Olsen AL,Swigris JJ,Lezotte DC,Norris JM,Wilson CG,Brown KK.Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003.Am J Respir Crit Case Med 2007;176:277-284.
  • 3Crystal RG,Bitteoman PB,Mossman B,Schwarz MI,Sheppard D,Almasy L,et al.Future research directions in idiopathic pulmonary fibrosis:summary of a National Heart,Lung,and Blood Institute working group.Am J Respire Crit Care Med 2002;166:236-246.
  • 4Moss M.Clinical year in review II.Interstitial lung disease,sepsis,pubnonary infections,and sleep medicine.Proc Am Thorax Soc 2007;4:482-488.
  • 5Noble PW,Homer RJ.Back to the future historical perspective on the pathogenesis of idiopathic palmary fibrosis.Am J Respire Cell Mol Biol 2005;33:113-120.
  • 6Scotton C,J,Chambers RC.Molecular targets in pulmonary fibrosis.The myofrroblast in focus.Chest 2007;132:1311-1312.
  • 7Tharmickal V J,Toews GB,White ES,Lynch JP 3rd,Maninez FJ.Mechanisms of pulmonary fibrosis.Annu Rev Med 2004;55:395-417.
  • 8Huminghake GW,Schwarz MI.Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis.Proc Am Thorax Soc 2007;4:449-452.
  • 9Eickelberg O,Panskg A,Koebler E,Bihl M,Tamm M,Hildebrand P,et al.Molecular mechanisms of TGF-βantagonism by interferon r and cyclosporine A in lung fibroblasts.FASEB J 2001;15:797-806.
  • 10Selman M,Thanmickal V J,Pardo A,Zisman DA,Martinez FJ,Lynch JP 3rd.Idiopathic pulmonary fibrosis.Pathogenesis and therapeutic approaches.Drug 2004;64:405-430.

同被引文献36

引证文献10

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部